Compare Allbirds Inc (BIRD) vs Sanofi SA (SNY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Allbirds Inc vs Sanofi SA — how do they compare? Allbirds Inc trades at $2.59 (market cap $30.00M), while Sanofi SA trades at $43.7 (market cap $104.30B). The key difference: Sanofi SA is far larger — about 3476.7× Allbirds Inc's market cap, and Sanofi SA pays a 5.55% dividend while Allbirds Inc pays none. Which is the better fit depends on your goals.
| BIRD | SNY | |
|---|---|---|
Market Cap | $30.00M | $104.30B |
Sector | Consumer Cyclical | Health |
52-Week High | $16.99 | $52.34 |
52-Week Low | $2.21 | $41.33 |
Enterprise Value | $48.86M | $124.19B |
Dividend Yield | — | 5.55% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Allbirds Inc
Allbirds Inc is a global lifestyle brand that innovates with naturally derived materials to make footwear and apparel products. Its primary source of revenue is from sales of shoes and apparel products in its directly owned digital and physical retail channels.
Read more on BIRD →About Sanofi SA
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →
